Document Detail

ADAMTS4 level in patients with stable coronary artery disease and acute coronary syndromes.
MedLine Citation:
PMID:  19944557     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: A recent study indicates that ADAMTS4 (a disintegrin and metalloprotease with thrombospondin motifs 4) was expressed in macrophage rich areas of human atherosclerotic carotid plaques and coronary unstable plaques suggesting a pathogenic role in the development of acute coronary syndromes (ACS). The aim of the study was to compare ADAMTS4 across the entire spectrum of coronary artery disease (CAD) and to investigate the temporal profiles of ADAMTS4. METHODS: Plasma levels of ADAMTS4 were measured in patients with stable effort angina pectoris (SAP), ACS and in controls. Venous blood was sampled upon admission before angiography and drug administration. In patients with ACS who underwent medical treatment, serial blood samples were also collected on days 1, 2, 3, 5 and 7 after admission. ADAMTS4 was measured using an enzyme immunoassay. RESULTS: Plasma ADAMTS4 level in cases was significantly greater than in controls (P<0.001). Higher levels of ADAMTS4 were found with progression of CAD from SAP to unstable angina pectoris (UAP) to non-ST-segment elevation acute myocardial infarction (NSTEMI) and to ST-segment elevation acute myocardial infarction (STEMI) (P<0.001). Elevated ADAMTS4 level was associated with ACS with an area under receiver operating characteristic (ROC) curve of 0.753 (95% CI 0.654-0.851; P<0.001). The pattern of ADAMTS4 release observed was clearly different in various forms of ACS. ADAMTS4 showed a weak correlation with high-sensitivity C-reactive protein (hs-CRP); however, no significant correlation was found between ADAMTS4 and troponin T (TnT) in ACS patients. CONCLUSIONS: Serial changes in plasma ADAMTS4 were documented in patients with ACS and may serve as a marker of plaque destabilization.
Yanping Zha; Yong Chen; Fayun Xu; Tian Li; Chuanyan Zhao; Lianqun Cui
Related Documents :
3978787 - Nickel concentrations in serum of patients with acute myocardial infarction or unstable...
1772707 - Increased plasma viscosity and erythrocyte aggregation: indicators of an unfavourable c...
2732767 - Comparison of a supplemented rose questionnaire to exercise thallium testing in men and...
224857 - Myocardial extraction of cyclic amp during pacing-induced angina.
15284267 - Using health-related quality of life measures to predict cardiac function in survivors ...
22104737 - Anesthetic management of vaginal delivery in a parturient with hemochromatosis induced ...
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't     Date:  2009-11-05
Journal Detail:
Title:  Biomedicine & pharmacotherapy = Biom?decine & pharmacoth?rapie     Volume:  64     ISSN:  1950-6007     ISO Abbreviation:  Biomed. Pharmacother.     Publication Date:  2010 Mar 
Date Detail:
Created Date:  2010-03-12     Completed Date:  2010-06-17     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8213295     Medline TA:  Biomed Pharmacother     Country:  France    
Other Details:
Languages:  eng     Pagination:  160-4     Citation Subset:  IM    
Copyright Information:
Copyright (c) 2009 Elsevier Masson SAS. All rights reserved.
Department of Cardiology, Provincial Hospital, Shandong University, Jinan, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
ADAM Proteins / blood*
Acute Coronary Syndrome / blood*
Angina Pectoris / blood*
Angina, Unstable / blood
Atherosclerosis / blood
Biological Markers
C-Reactive Protein / analysis
Coronary Angiography
Middle Aged
Myocardial Infarction / blood*,  classification
Procollagen N-Endopeptidase / blood*
Rupture, Spontaneous
Time Factors
Troponin T / blood
Reg. No./Substance:
0/Biological Markers; 0/Troponin T; 9007-41-4/C-Reactive Protein; EC 3.4.24.-/ADAM Proteins; EC 3.4.24.-/aggrecanase-1; EC N-Endopeptidase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Retrospective study on six years of anaesthesia for reduction of shoulder dislocation in emergency.
Next Document:  Time-course of health status in patients with rheumatoid arthritis during the first year of treatmen...